More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to ...

Insulin then lowers your blood sugar levels in several ways. On the other hand, when your blood sugar levels drop too low, your pancreas releases the hormone glucagon, which raises your blood ...

According to nutritionist Ángela Quintas it all comes down to what you’re eating—and, more specifically, how it impacts your ...

A Cell Metabolism study finds that while high-GI meals spike insulin and glucose, they don’t increase hunger or consistently ...

For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced ...

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

A Columbia University dermatologist argues that physicians in her specialty should be on the lookout for metabolic syndrome ...

Insulin resistance in T1D is more common than you think, and without early intervention, these patients face increased risks ...

Whether you are watching television, scrolling through Instagram, or catching up with an old friend, the topic of weight loss ...

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

HealthDay News — For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor ... developing hematologic cancers compared with insulin and metformin use, according to a research ...